Table 3.
Correlations between self-reported varenicline pill count and varenicline plasma levels.
| Measures of adherence | Plasma varenicline (ng/ml) | 3-Day pill count | 7-Day pill count | 14-Day pill count | 12-Week pill count |
|---|---|---|---|---|---|
| Plasma varenicline (ng/ml) | 1 | – | – | – | – |
| 3-Day Pill Count | 0.23 (0.05) | 1 | – | – | – |
| 7-Day Pill Count | 0.21 (0.07) | 0.83 (<0.001) | 1 | – | – |
| 4-Week Pill Count | 0.24 (0.04) | 0.58 (<0.001) | 0.68 (<0.001) | 1 | – |
| Total Pill Count | −0.02 (0.90) | 0.45 (<0.001) | 0.48 (<0.001) | 0.75 (<0.001) | 1 |
Note. Spearman correlation coefficients are displayed. p-Values (2-tailed) are indicated in brackets. Higher values reflect greater adherence.
Bold numbers indicate significant correlations between plasma varenicline and self-report measure.